Abstract | BACKGROUND: METHODS: Nineteen patients with symptoms and signs of AC ( itching, discharge, burning, redness, increase in the watery discharge, swelling and follicles) and with a history of allergy were prescribed with two daily instillation of one drop of eyewash ketotifen fumarate 0,05% in both eyes during thirty days. They were studied by measuring clinical and immunologic parameters. RESULTS:
Ketotifen fumarate treatment significantly reduced the total symptoms and signs score for each patient as well as each symptoms and signs at all time points compared with day 0 (p < 0.0001 and p < 0.016, respectively). Although the percentage of HLA-DR+ epithelial cells diminished only in 58% of patients, the numbers of CD29+ and eotaxin+ epithelial cells dropped significantly in 68% and 73 % of them (p < 0.0062 and <0.0082, respectively) as a consequence of the treatment. In 9 out of 19 patients a simultaneous decrease in the percentage of epithelial cells positive for CD29 and eotaxin was observed. CONCLUSION:
Ketotifen besides the well-known effect in reducing signs and symptoms of AC significantly diminished production of eotaxin and expression of CD29 by epithelial cells in patients with seasonal AC.
|
Authors | Andrea P Martín, Julio Urrets-Zavalia, Alejandro Berra, Ana Lía Mariani, Norberto Gallino, Eduardo Gomez Demel, Julio Gagliardi, Carlos E Baena-Cagnani, Enrique Urrets-Zavalia, Horacio M Serra |
Journal | BMC ophthalmology
(BMC Ophthalmol)
Vol. 3
Pg. 2
(Jan 06 2003)
ISSN: 1471-2415 [Electronic] England |
PMID | 12515585
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Biomarkers
- CCL11 protein, human
- Chemokine CCL11
- Chemokines, CC
- Chemotactic Factors, Eosinophil
- HLA-DR Antigens
- Histamine H1 Antagonists
- Integrin beta1
- Ophthalmic Solutions
- Ketotifen
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Biomarkers
(analysis)
- Chemokine CCL11
- Chemokines, CC
(metabolism)
- Chemotactic Factors, Eosinophil
(metabolism)
- Child
- Conjunctiva
(drug effects, metabolism)
- Conjunctivitis, Allergic
(drug therapy, metabolism)
- Epithelial Cells
(drug effects, metabolism)
- Female
- HLA-DR Antigens
(metabolism)
- Histamine H1 Antagonists
(administration & dosage, therapeutic use)
- Humans
- Integrin beta1
(metabolism)
- Ketotifen
(administration & dosage, therapeutic use)
- Male
- Middle Aged
- Ophthalmic Solutions
|